Exhibit 23.1 

Consent of Independent Registered Public Accounting Firm 

We consent to the use of our report dated March 6, 2024, with respect to the consolidated financial statements of Seelos Therapeutics, Inc., incorporated herein by reference, and to the reference to our firm under the heading "Experts" in the prospectus. 

/s/ KPMG, LLP 

Short Hills, New Jersey

September 24, 2024